Why Fertility Patients Walk Away From Treatment

The Billing Friction Driving Discontinuation

July 3, 2026

In a field where the medical complexity is the obvious challenge, the financial complexity is often the deciding one. The clinics that recognize this are quietly changing their patients' outcomes alongside their own.

The Most Important Number in Fertility Care Isn't a Success Rate

Of patients who discontinue fertility treatment, 62% cite financial burden as the primary reason (source). It is not lack of medical hope. It is not poor outcomes from the first attempt. It is the math.

The picture deepens when you look at the broader patient survey data:

  • 70% of women who undergo IVF report going into debt to pay for it (source)
  • 34% stop treatment because they can't afford to continue (source)
  • 86% of fertility patients have forgone or would consider forgoing a doctor-recommended treatment because of cost (source)
  • Patients without IVF insurance coverage are three times more likely to discontinue after just one cycle than those with coverage (source)

Figure 1

The Cost of a Broken Billing Experience

Most fertility patients who walk away from treatment don't walk away because the science failed. They walk away because the math became impossible.

70%
of women who undergo IVF go into debt to pay for it
34%
stop fertility treatment because they can't afford to continue
62%
of patients who discontinue cite financial burden as the primary reason
86%
have forgone or would forgo a doctor-recommended treatment because of cost

Sources: ASRM Ethics Committee Opinion on Disparities in Access (2021); Inside Reproductive Health (2025) via Fertility Bridge; Cofertility Patient Survey (fielded 2019, published 2022).

These are not patients who decided not to have a family. These are patients who wanted to keep going and couldn't see a way to pay for it.

Why This Matters Clinically

Fertility care is one of the few specialties where the path to a successful outcome is, on average, multi-cycle. More than 70% of patients require more than one cycle to achieve success (source). When a patient discontinues after cycle one because of cost, they are walking away before the typical course of treatment has even completed.

That has clinical consequences that don't show up in the success rate disclosures:

  • Patients who discontinue early skew the practice's outcome data downward, because they leave before the typical cumulative success threshold is reached
  • The patient receives an incomplete course of care, often without ever telling the practice why
  • The practice loses both the revenue and the relationship, often without realizing the loss happened for financial reasons rather than medical ones

This is not a billing problem dressed up as a clinical one. It is a clinical problem that runs through billing.

What Financial Friction Actually Looks Like

The friction points that drive discontinuation are usually small individually and devastating in combination:

  • A bill arrives weeks after a phase of treatment, by which point the patient has already moved on emotionally
  • The bill doesn't match the estimate, and the patient can't tell why
  • The patient has to call the office during business hours to ask what they owe and how to pay
  • There is no payment plan available, so a $9,000 balance has to be paid as a lump sum
  • The patient has multiple bills from the practice, the lab, the pharmacy, and the anesthesia group, and no way to see the full picture
  • A declined card silently fails, and the patient never gets a clear notification

Most patients won't tell the practice that any of this is what made them stop. They will simply not schedule the next cycle, and the staff will assume the patient changed their mind.

Prior Authorization Is Its Own Trap

There is a related friction worth naming separately. Prior authorization, in fertility care, is uniquely punishing. Ovulation windows don't wait for a payer to respond. A delay of two weeks isn't an inconvenience; it can mean a missed cycle.

The toll on patients is documented. 78% of physicians report that prior authorization processes "often or sometimes" result in patients abandoning recommended treatment, and 24% report that prior authorization has caused a serious adverse patient event (source). Fertility, where the timing of every clinical decision is biologically constrained, is one of the specialties where this hits hardest.

Prior auth friction isn't a billing problem in the strict sense. It is an upstream insurance and intake problem. The reason it belongs in the same conversation is that the patient experiences it as one continuous wall of administrative weight, and the practice that can verify eligibility quickly, surface coverage gaps before treatment begins, and keep the patient moving through the cycle is the practice that retains them.

What Practices Can Do

The practices that are reducing financial-driven discontinuation tend to share a few habits.

They lead with payment plans, not lump sums. Financial counseling at the start of treatment includes a structured plan that breaks the total into manageable installments aligned with the cycle. Patients who can see a path to paying are far more likely to stay on it.

They make payment effortless after the counseling visit ends. Mobile-first delivery, autopay, and the ability to pay in seconds without logging into anything turn payment from a recurring stressor into a non-event. Roughly 44% of electronic statements result in immediate payment, compared to about 2% for paper statements (source).

They keep estimates honest and updates real-time. When a clinical decision changes the cost picture, the patient hears about it the same day, not three weeks later when the bill arrives.

They treat billing as part of the care relationship. A patient who feels respected by the financial experience of treatment is dramatically more likely to complete it.

The Business Case Is the Same as the Clinical One

Reducing financial-driven discontinuation is one of the highest-leverage actions a fertility practice can take. The patient who completes a second cycle delivers a second cycle's revenue, and is more likely to refer, more likely to leave a positive review, and more likely to come back for a sibling.

Cost is the leading reason women cannot obtain fertility care in the first place, and 1 in 8 reproductive-age women report they need fertility services (source). The gap between need and access is large, and it is driven almost entirely by financial barriers. The practices that close that gap inside their own walls, by removing the friction that turns financial barriers into clinical drop-off, are the ones whose patients finish their cycles and tell their friends.

Where PatientPay Fits

PatientPay was built around this dynamic. Mobile-first statements, payment plans tied to cycle milestones, autopay, and a friction-free experience that doesn't require a portal or login all serve the same purpose: keep the financial side of treatment from becoming the reason the medical side ends.

A patient who stops treatment because they can't afford to continue is not a patient the practice has lost. They are a patient the practice never finished serving.